SLC25A21 and acute myeloid leukemia: The primary biological functions of SLC25A21 were suppressed after CXCL8 overexpression in vitro, confirming the tumor-promoting action of CXCL8. The exact mechanism by which the SLC25A21 regulates CXCL8 in AML remains unclear, and much work needs to be done in our subsequent studies.